Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
Official title: Construction and Empirical Research of a Risk Prediction Model for Preventing Lower Extremity Arteriosclerosis Obliterans in Diabetic Patients Based on the HAPA Model
Run by Second Affiliated Hospital of Nanchang University · NCT07881588 · Data updated 2026-11-12
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 154 (estimated) |
| Sponsor | Second Affiliated Hospital of Nanchang University Academic / other |
| Locations | 1 site (Nanchang, Jang XI) |
| Status | Recruiting |
| Started | April 15, 2025 |
| Main results expected | October 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT07881588 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with type 2 diabetes, at risk for ASO, and capable of using smart devices and providing informed consent.
✕Probably not a fit
Patients with severe cognitive impairment, active mental illness, or existing lower-extremity arterial disease may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study develops a logistic regression–based risk model to predict lower extremity arteriosclerosis obliterans (ASO) in diabetic patients. Guided by the Health Action Process Approach (HAPA), investigators create and test a nursing intervention aimed at preventing ASO. The trial compares routine care to the targeted intervention to see if the risk model and nursing plan can lower ASO incidence and improve quality of life in clinical practice. Participants are adults with type 2 diabetes, able to use smart devices, and able to consent. The study is conducted at a single center, with the aim of informing practical prevention strategies in diabetic care.
Why it matters
Potential benefit: If successful, patients may experience a lower risk of ASO and improved quality of life through tailored prevention.
How similar studies have gone: Previous work with risk-prediction models and HAPA-based interventions in chronic disease prevention has shown promise, though this exact combination in diabetic ASO prevention is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Meet the clinical diagnostic criteria for type 2 diabetes; * Age ≥18 years old; * The patient is conscious, has no language communication barriers, and has certain reading and writing abilities. * The patient or caregiver can use smart devices. * Informed consent and voluntary participation. Exclusion Criteria: * Those with severe audio-visual or cognitive impairments; * Combined with other serious physical diseases, such as malignant tumors, etc. * Have a history of mental illness; * Patients who already have lower extremity arterial disease.
Where it's running
-
The Second Affiliated Hospital of Nanchang University
Nanchang, Jang XI, China Recruiting
Study contacts
- Study coordinator: Yujin Yang
- Email: 18979136718@163.com
- Phone: 18979136718
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Integrated care for older patients with atrial fibrillation
This study is testing a new team-based care approach for older patients with atrial fibrillation and other health issues to see if it helps them manage their condition better than regular care.
-
Early angioplasty for diabetic foot syndrome
This study is testing if getting a quick angioplasty after being diagnosed with diabetic foot ulcers helps heal the wounds better than waiting for the procedure.
-
Research on health inequality and genetic disparity in cardiovascular diseases
This study is trying to understand how health differences and genetics affect heart diseases in people from various ethnic backgrounds in the UK to help improve treatments for everyone.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.